Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Plasma SCUBE1 and sCD40L Concentration in CAD, ACS, and Acute Stroke Patients

Plasma concentration of signal peptide–complement proteins C1r/C1s, Uegf, and Bmp1–epidermal growth factor-like domain containing protein 1 (SCUBE1) and sCD40L in cases (coronary artery disease [CAD], acute coronary syndromes [ACS], acute ischemic stroke) versus healthy control subjects (A), and in subgroup analyses (B). For SCUBE1, p < 0.01 after Bonferroni correction in ACS versus control subjects and acute ischemic stroke versus control subjects. For sCD40L, *p = 0.02, **p < 0.01 after Bonferroni correction. LAT = large-vessel atherothrombotic; NSTEMI = non–ST-segment elevation myocardial infarction; SL = small lacunar stroke; STEMI = ST-segment elevation myocardial infarction; TIA = transient ischemic attack; UA = unstable angina; VD = vessel-disease.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement